SCHEMBL6312291

SCHEMBL6312291

CCCCc1c(C2CC2)c(C#N)c2nc3ccccc3n2c1N1CC[C@H](N(C)C)C1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.49
NPSR1 Q6W5P4 4/20 0.49
SMN1; SMN2 Q16637 3/20 0.49
HPGD P15428 2/20 0.49
MAPT P10636 2/20 0.49
RAB9A P51151 2/20 0.49
HTT P42858 1/20 0.49
MEN1 O00255 3/20 0.47
HIF1A Q16665 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
ALDH1A1 P00352 7/20 0.44
KDM4E B2RXH2 3/20 0.44
GAA P10253 3/20 0.44
LMNA P02545 3/20 0.44
GLA P06280 2/20 0.44
RXFP1 Q9HBX9 2/20 0.44
RECQL P46063 1/20 0.44
TSHR P16473 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6312844 0.87 L3MBTL1 (0.59) KMT2ANPSR1SMN1; SMN2HPGDMAPT
Formic Acid SCHEMBL6313188 0.86 NPSR1 (0.54) KMT2ANPSR1SMN1; SMN2HPGDMAPT
SCHEMBL6312289 0.84 KMT2A (0.50) KMT2ANPSR1SMN1; SMN2HPGDMAPT
SCHEMBL6311130 0.83 HIF1A (0.57) KMT2ANPSR1SMN1; SMN2HPGDMAPT
Hydrochloric Acid SCHEMBL6311165 0.82 HIF1A (0.55) KMT2ANPSR1SMN1; SMN2HPGDMAPT
SCHEMBL6314338 0.82 HIF1A (0.56) KMT2ANPSR1SMN1; SMN2HPGDMAPT
SCHEMBL6319416 0.81 HIF1A (0.51) KMT2ANPSR1SMN1; SMN2HPGDMAPT
SCHEMBL6312823 0.80 L3MBTL1 (0.62) KMT2ANPSR1SMN1; SMN2HPGDMAPT
SCHEMBL6311360 0.79 KMT2A (0.51) KMT2ANPSR1SMN1; SMN2HPGDMAPT
SCHEMBL6310420 0.79 NPSR1 (0.74) KMT2ANPSR1SMN1; SMN2HPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050113397-A1 Imidazo[1,2-a]pyridine derivative DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2005-05-26 US disclosed
EP-1479681-A1 IMIDAZO(1,2-a)PYRIDINE DERIVATIVE DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2004-11-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113397-A1 Imidazo[1,2-a]pyridine derivative MANBA, MAN2B1, ERG28 KMT2A 4210/4885NPSR1 1531/4885SMN1; SMN2 2642/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.